Kappa-opioid receptors (KOR) control dopamine (DA) levels in the striatum and contribute significantly to the progression of drug addiction. Repeated exposure to psychostimulants has been associated with up-regulated KOR activity and increased DA levels in dorsal striatum. However, it has not been tested if both processes are linked. In this work, we studied if a mechanism mediated by KOR is contributing to the increase in DA levels in the dorsolateral striatum (DLS) after amphetamine (AMPH) sensitization. The AMPH sensitization was assessed after single or repeated once-a-day AMPH injections (1 mg/kg). Only repeated AMPH exposure produced a significant locomotor sensitization. No-net flux microdialysis was used to assess basal DA dialysate, DA extracellular concentration (C ext ), and DA uptake in DLS of anesthetized rats. The role of KOR on DA dynamics in DLS was evaluated by local perfusion (250 lM) and systemic administration (10 mg/kg) of the KOR antagonist nor-binaltorphimine. A significant decrease in DA C ext is observed in the DLS after an AMPH challenge in rats exposed to a single dose of AMPH. The decrease in DA C ext was associated with both a decreased basal DA dialysate and an increased DA uptake. Conversely, the expression of AMPH sensitization was accompanied by a significant increase in DA C ext associated with an increased basal DA dialysate and an attenuation in DA uptake. Both local and systemic administration of norbinaltorphimine reversed changes in DLS after AMPH pretreatment. These findings indicate that endogenous KOR system tunes DLS DA dynamics during the progression to AMPH sensitization.
It has been consistently reported that repeated administration of amphetamine (AMPH) and cocaine facilitates dopamine (DA) release in the nucleus accumbens (NAc) and dorsal striatum (Castañeda et al. 1988; Kantor et al. 1999; Escobar et al. 2012; Pierce and Kalivas 1997) . The mesolimbic DA sensitization contributes to pathological drug craving and relapse to drug seeking after long abstinence period (Robinson and Berridge 1993) . The dorsal striatum has also been associated with addiction, particularly with the habitual drug intake (Everitt et al. 2001) . During the repeated intake of cocaine, an increase in phasic DA release emerges in the dorsolateral striatum (DLS), which is accompanied by attenuation in DA release in the NAc. This DA sensitization takes place progressively and would be responsible for biasing the behavior toward reinforced action (Willuhn et al. 2012) .
The kappa-opioid receptors (KOR) control DA extracellular levels and contribute significantly to the progression of drugs addiction. The KOR signaling has been associated with physiopathology (Shippenberg et al. 2007 ) and treatment of drug addiction (Koob and Mason 2016 ). An increase in dynorphin, the endogenous ligand of KOR is observed in the striatum after cocaine (Valenza et al. 2017) and AMPH (Tzaferis and McGinty 2001) exposure. In this sense, the antagonism of KOR has been proposed as a pharmacological tool to treat drugs addiction (Wee and Koob 2010) .
The relevance of KOR in the addiction lies in its complex control on DA neurotransmission, characterized by apparently contradictories effects on DA release. The acute activation of KOR produces a decrease in NAc DA release (Di Chiara and Imperato 1988) and dorsal striatum (Gehrke et al. 2008) . The local infusion of the KOR antagonist increases DA basal levels in the NAc (Spanagel et al. 1992) , showing an inhibitory tonic control of KOR on DA extracellular levels. Accordingly, the acute activation of KOR attenuates the increase in DA release induced by AMPH (Gray et al. 1999) and cocaine (Maisonneuve et al. 1994) . Interestingly, after the early attenuation of cocaineinduced DA release, the acute activation of KOR results in a relative increase in cocaine-induced DA release in NAc (Ehrich et al. 2014) . This biphasic control of KOR on DA release has been associated with aversive and delayed rewarding effects after the acute activation of KOR (Chartoff et al. 2016) . Moreover, we showed that repeated activation of KOR produces an increase in stimulated DA release in the NAc (Fuentealba et al. 2006 (Fuentealba et al. , 2007 . These results suggest that protracted activation of KOR results in sensitization of DA release in the mesolimbic pathway. Although the KOR activity is increased after the repeated exposure to psychostimulants in NAc and dorsal striatum (Turchan et al. 1998) , whether a KOR mechanism contributes to DLS DA sensitization observed after the repeated exposure to psychostimulant (Willuhn et al. 2012) remains unknown.
The KOR control extracellular DA concentration (DA C ext ) influencing both the release and uptake of DA. The acute activation of KOR increases the DA uptake in the NAc, while the repeated activation of KOR decreases DA uptake in the NAc (Thompson et al. 2000) . The systemic administration of the long-lasting KOR antagonist nor-binaltorphimine (nor-BNI) is accompanied by an early increase in DA release and a subsequent increase in DA uptake in the NAc (Chefer et al. 2005 (Chefer et al. , 2006 . These data have been interpreted as compensatory changes to maintain homeostatic levels of DA C ext . Regard to the dorsal striatum, one study has shown that repeated activation of KOR does not modify DA uptake (Thompson et al. 2000) . Then, while the evidence points to a possible interaction between KOR and dopamine transporter (DAT) (Svingos et al. 2001; Kivell et al. 2014) , the effect of endogenous KOR tone on dorsal striatum DA uptake is not fully elucidated. This study addresses the contribution of endogenous KOR tone to DA dynamics in the DLS after locomotor AMPH sensitization. Microdialysis no-net flux was carried out to assess the effect of KOR antagonist nor-BNI on release and uptake of DA in DLS after single and repeated exposure to AMPH.
Material and methods
The study was not pre-registered. All procedures were in strict accordance with the guidelines published in the 'NIH Guide for the Care and Use of Laboratory Animals' (8°Edition) and the principles presented in the 'Guidelines for the Use of Animals in Neuroscience Research' by the Society for Neuroscience. Also, the protocols were approved by the local bioethics committees (Project #1141088). The rats were identified with markings on the tail and numbered accordingly. Using a pseudo randomization (random number generator) the animals were divided into two experimental groups (no-net flux microdialysis and conventional microdialysis). Each group was subdivided using the same method into three groups (control, single exposure to AMPH, and repeated exposure to AMPH). All control and experimental protocols were performed in parallel. A priori statistical power, effect, and sample size calculations were performed by [G*power (Faul et al. 2007 ), a = 0.05; power > 0.8] based on preliminary results of this study. The results obtained suggested a sample size of n = 5/group for experiment. Exact numbers for all experiments are provided in the figure legends and results section.
Animals
Adult male Sprague-Dawley rats (300-340 g) were grown from the Animal Care Faculty of the Biological Sciences, Pontificia Universidad Catolica de Chile (Charles River; Wilmington, MA, USA; research resource identifiers: RGD_728193), under the supervision of a veterinarian. During drug treatment, rats were maintained in the Animal Care Faculty of the Department of Pharmacy, Pontificia Universidad Cat olica de Chile, following the instruction of a protocol approved by the veterinarian. Rats were housed in groups of three per cage and kept at a room temperature between 22 and 24°C on a 12 h light/dark cycle (lights on at 7:00 EST) with access to food and water ad libitum. Rats were handled for 1 week before starting the experiments. A total of 65 rats were divided into two groups; 30 rats for no-net flux microdialysis and 35 rats for conventional microdialysis experiments. Forty rats were used to measure locomotor activity induced by AMPH before microdialysis experiments. No animals died during the experiments. Only one animal was excluded of the no-net flux group (single AMPH/saline, Fig. 2) because it was not possible to quantify all of it samples by high performance liquid chromatography (HPLC).
Reagents
Amphetamine chloride was obtained from the Public Health Institute of Chile (Santiago, Chile) and dissolved in NaCl 0.9% at concentration of 0.9 mg/mL. The kappa-opioid antagonist nor-BNI was purchased from Abcam (Product code: ab120078, Cambridge, MA, USA) and was dissolved in saline and freshly prepared on the day of the experiment.
Amphetamine locomotor sensitization
Animals were habituated to the test cages (15 9 47 9 26 cm 3 ) for 30 min before the injection of amphetamine or an equivalent volume of saline. After 30 min, the rats were injected and immediately transferred to test cages equipped with two pairs of infrared lights. Crossovers in the test cage were monitored every minute for 50 min, using a counting device programmed to count only when both infrared light beams were interrupted consecutively. Locomotor AMPH sensitization was evaluated after a single and repeated exposure to AMPH (Vanderschuren et al. 1999) . The process of AMPH locomotor sensitization was developed according to a schedule as described previously (Aguilar-Rivera et al. 2015) (Fig. 1a) . Rats were injected once daily (12:00 PM EST) with AMPH (1.0 mg/kg) or an equivalent volume of saline, during five consecutive days (Days 1-5). After 5 days of abstinence (Days 6-10), rats pre-exposed to saline or AMPH were injected with a challenge dose of AMPH (1.0 mg/kg) (Day 11). In saline preexposed rats, the expression of AMPH sensitization was assessed with a second injection of AMPH 3 days after the challenge dose of AMPH (Day 15, Fig. 1a) . In AMPH pre-exposed rats, the locomotor expression was re-evaluated on day 15. In AMPH pre-exposed rats group, we consider locomotor sensitization when the rat has at least doubled the crossover/50 min on the 11th day compared with the 1st day. The animals that did not meet this criterion were excluded from data. To assess the effect of blocking KOR on AMPH sensitization, the long-lasting KOR antagonist nor-BNI (10 mg/kg) (Broadbear et al. 1994) was injected 24 h after the acute AMPH challenge (Day 12). Both no-net flux and conventional microdialysis experiments were carried out 24 h after the expression of AMPH locomotor sensitization (Day 16, Fig. 1a) .
Microdialysis experiments
Rats were anesthetized with urethane 1.5 g/kg i.p and placed in a stereotaxic apparatus. The urethane was chosen because of the extended half-time. The skull of the rat was exposed, and a hole was drilled targeting the DLS. A concentric microdialysis probe (CMA 11 Microdialysis, Holliston, MA, USA) was lowered into the DLS using the following coordinates: +1.2 AP, +3.6 ML, and À4.8 DV relative to bregma (Paxinos and Watson 2009) . Body temperature was maintained by a thermostatically controlled electric heating pad. The microdialysis probe was perfused for 40 min to allow equilibration with Krebs-Ringer phosphate (KRP) buffer at a rate of 2 lL/min using a Harvard infusion pump (Harvard Apparatus, Holliston, MA, USA). The composition of the KRP was 120 mM NaCl, 2.4 mM KCl, 1.2 mM CaCl 2 , 0.9 mM NaH 2 PO 4 , 1.4 mM Na 2 HPO 4 , and 0.2 mM of ascorbic acid (pH 7.4). Perfusion samples were collected every 5 min in 2 lL of perchloric acid (0.2 N) and maintained on ice (4°C) until DA determination. In the no-net flux microdialysis, the probe was randomly perfused with four different concentrations of dopamine: 0.0, 5.0, 20.0, and 40.0 nM in a KRP to determine DA C ext and extraction fraction (Ed), an indirect measure of DA uptake (Smith and Justice 1994) . A random number generator method was applied for perfusion of different concentrations of DA. After a stabilization period of 30 min, three consecutive samples were collected every 5 min for each concentration of DA. To assess the effect of blocking KOR on DA dynamics, a group of rats was continuously perfused with nor-BNI (250 lM) through microdialysis probe. This nor-BNI concentration previously showed to increase significantly basal DA dialysis levels in DLS ( Figure S1 ). In the conventional microdialysis, after 40 min of stabilization period, three consecutive samples were collected every 5 min for determination of an average DA basal level. DA release was stimulated during 5 min using 40 mM and 70 mM K + -KRP. Also, DA release was stimulated perfusing 100 lM AMPH-KRP. Three consecutive samples were collected after each stimulus period, separated by 30 min of stabilization period between stimuli. The end of the microdialysis was the endpoint of the experiments. After that, rats were decapitated under deep anesthesia (urethane 1.5 g/kg i.p), and brains sections were stained with cresyl violet to verify probe location (Fig. 1b) .
Analysis of dialysate samples
Quantification of DA was carried out as described previously (Escobar et al. 2012) . Ten lL of the collected samples was injected in a Rheodyne injector valve to a HPLC system (BASi America, West Lafayette, IN, USA) with the following configuration: a pump (Jasco LC-Net II/ADC), a UNIJET TM LC column (part number: MF-8954; BASi), and an amperometric detector (LC4C; BASi America). The mobile phase contained 100 mM NaH 2 PO 4 , 1.0 mM EDTA, 1.0 mM octane-1-sulfonic acid sodium salt, and 3% acetonitrile (pH 3.0), and it was pumped at a flow rate of 700 lL/min. The potential of the amperometric detector was set at 650 mV. Under these experimental conditions, the retention time for DA was 6 min. The technician was blinded to the experimental group during the measurement of the samples in the HPLC.
Data analysis
No-net flux microdialysis data were analyzed as described by Chefer et al. (2005 Chefer et al. ( , 2006 . The amount of DA gained or lost from the probe during the no-net flux microdialysis (C in À C out ) was calculated for each animal at each DA perfusion concentration (C in : 0.0, 5.0, 20.0, and 40.0 nM). The net change in DA (C in À C out ) was plotted against C in and subjected to linear regression. The point when no DA was gained or lost (C in À C out = 0) represents an estimate of DA C ext . The slope of the linear regression line represents the Ed ( Figure S2 ). Basal dialysate DA levels were calculated for each animal as the average of the three basal samples (C in = 0). All statistical analyses were performed using Prism 5.0 GraphPad Software; GraphPad Software Inc., San Diego, CA, USA. Data points outside the 95% confidence interval are treated as outliers and could be excluded from the data analysis. Neither point was excluded from the data analysis. Normality was checked with the Kolmogorov-Smirnov test. Resultant data were analyzed by twoway ANOVA, one-way ANOVA, and Bonferroni post-test; unpaired and paired t-test when appropriate. All data are reported as mean AE SEM.
Results
Rats were injected once daily with AMPH (1.0 mg/kg) or saline, during five consecutive days (Days 1-5). Rats preexposed to saline or AMPH were injected with a challenge dose of AMPH (1.0 mg/kg) (Day 11). In saline pre-exposed rats, the expression of AMPH sensitization was assessed with a second injection of AMPH, 3 days after the challenge dose of AMPH (Fig. 1a, day 15) . In AMPH pre-exposed rats, the locomotor expression was re-evaluated on day 15. To study the effect of AMPH exposure on DA dynamics in the DLS, microdialysis no-net flux was carried out 24 h after the last injection of AMPH (Fig. 1a, day 16 ). Rats repeatedly treated with AMPH showed a significant locomotor sensitization (day 11: 101.06 AE 19.19 crossings/50 min vs. day 15: 16.80 AE 14.36 crossings/50 min, p < 0.05 according to Bonferroni post-test) compared with single-dose AMPH pre-exposed rats (day 11: 72.50 AE 11.34 crossings/50 min vs. day 15: 93.13 AE 14.36 crossings/50 min). To assess the contribution of KOR to changes in DA dynamics induced by AMPH exposure, nor-BNI (250 lM) was perfused into DLS during the no-net flux microdialysis (Fig. 1a, day 16 ).
Effect of DLS nor-BNI perfusion on basal DA dialysate levels In saline control rats the local perfusion of nor-BNI is accompanied by a significant increase in basal DA dialysate (Fig. 2a : control/saline: 0.57 AE 0.06 nM; n = 5; vs. control/ nor-BNI: 0.99 AE 0.17 nM; n = 5; p < 0.05 according to unpaired t-test). Surprisingly, single-dose AMPH preexposed rats showed a significant decrease in basal DA dialysate (single AMPH/saline: 0.33 AE 0.07 nM; n = 4; vs. AMPH sensitized/saline: 1.49 AE 0.25 nM; n = 5; p < 0.05 according to Bonferroni post-test). A non-significant increase in basal DA dialysate is observed during the nor-BNI perfusion in single-dose AMPH pre-exposed rats. In AMPHsensitized rats, the increase in the basal DA dialysate was significantly attenuated during the perfusion of nor-BNI (AMPH sensitized/saline: 1.49 AE 0.25 nM; n = 5; vs. AMPH sensitized/nor-BNI: 0.66 AE 0.15 nM; n = 5; p < 0.05 according to Bonferroni post-test). Fig. 1 (a) Day-by-day protocol used to study the effect of blocking kappa-opioid receptors on locomotor activity after single (n = 20) and repeated exposure to amphetamine (AMPH) (n = 20). Only rats that express locomotor sensitization after AMPH pre-pretreatment (day 1-5) were used for the following experiments (Day 11, first exclusion criteria; see material and methods). On day 12, AMPH-sensitized rats were splited into two groups and injected with saline or norbinaltorphimine (nor-BNI): AMPH sensitized/saline (n = 10) and AMPH sensitized/nor-BNI (n = 10). Also, on day 12 saline pre-treated rats were splited into two groups after an acute injection of AMPH (day 11), and injected with saline or nor-BNI: single AMPH/saline (n = 10) and single AMPH/nor-BNI (n = 10). Both no-net flux and conventional microdialysis experiments were carried out 24 h after the expression of AMPH sensitization (day 16). One rat of single AMPH/saline group was excluded (Day 16, second exclusion criteria; see material and method). in control (control/saline n = 5 rats; control/ nor-BNI n = 5 rats) and AMPH exposed rats (single AMPH/saline n = 4 rats; single AMPH/nor-BNI n = 5 rats; AMPH sensitized/saline n = 5 rats; AMPH sensitized/ nor-BNI n = 5 rats). Krebs-Ringer phosphate nor-BNI (250 lM) was continuously perfused during the microdialysis experiments. Data correspond to mean AE SEM. 
Effect of DLS nor-BNI perfusion on Ed
In saline control rats the local perfusion of nor-BNI is accompanied by a significant increase in Ed (Fig. 2b : control/saline: 0.26 AE 0.01; n = 5; vs. control/nor-BNI: 0.37 AE 0.04; n = 5; p < 0.05 according to unpaired t-test). A one-way ANOVA analysis showed a significant increase in Ed in single-dose AMPH pre-exposed rats (control/saline: 0.26 AE 0.01; n = 5; vs. single AMPH/saline: 0.60 AE 0.04; n = 4; p < 0.05 according to Bonferroni post-test). The nor-BNI attenuated the increase in Ed observed in singledose AMPH pre-exposed rats (single AMPH/saline: 0.60 AE 0.04; n = 4; vs. single AMPH/nor-BNI: 0.36 AE 0.05; n = 5; p < 0.05 according to Bonferroni post-test). The AMPH-sensitized rats show an increase in Ed in the DLS which reaches a significant difference after nor-BNI ( Fig. 2 : control/saline: 0.26 AE 0.01; n = 5; vs. AMPH sensitization/nor-BNI: 0.52 AE 0.04; n = 5; p < 0.05 according to Bonferroni post-test). These results indicate that nor-BNI-modified DA uptake as a function of AMPH pre-exposure.
Effect of DLS nor-BNI perfusion on DA C ext
In control rats, the DA C ext was unaltered after the local perfusion of nor-BNI. A one-way ANOVA analysis showed that the pre-exposure to a single dose of AMPH is accompanied by a significant decrease in DA C ext compared with AMPH-sensitized rats (Fig. 2c , single AMPH/saline: 0.34 AE 0.15; n = 4; vs. AMPH sensitized/saline: 2.18 AE 0.38; n = 5; p < 0.05 according to Bonferroni post-test). The perfusion of nor-BNI in single-dose AMPH pre-exposed rats tends to increase the DA C ext , while a tendency to decrease DA C ext is observed in AMPH-sensitized rats.
To determine the effect of blocking KOR on AMPHinduced locomotor activity, an acute systemic injection of nor-BNI (10 mg/kg) was administered to rats pre-exposed to a single or repeated dose of AMPH (Fig. 1a, day 12) . Previous studies have shown that this dose of nor-BNI exhibits anti-craving (Smith et al. 2012 ) and anxiolytic (Knoll et al. 2007 ) properties ( Figure S3 ).
Effect of systemic nor-BNI on locomotor expression after single or repeated AMPH exposure A two-way ANOVA, with treatment conditions as the betweensubjects variables and days as the within-subjects variable, showed a significant effect of treatment (F 3,48 = 40.54; p < 0.0001) and the days (F 3,48 = 87.09; p < 0.0001). The interaction is also considered significant (F 9,48 = 12.65; p = 0.0001) (Fig. 3) . In this regard, only the repeated AMPH administration produces a significant increase in the horizontal locomotor activity after an AMPH challenge (day 1: 40.20 AE 14.55 crossings/50 min; n = 5; vs. day 15: 183 AE 10.76 crossings/50 min; n = 5; p < 0.001, according to Bonferroni post-test). As shown in Fig. 3 , the systemic administration of nor-BNI (Day 12) did not modify the AMPH-induced locomotor activity in both single-dose AMPH pre-exposed rats (Day 15: single AMPH/saline: 41.00 AE 4.44 crossings/50 min; n = 5; vs. single AMPH/ nor-BNI: 35.00 AE 5.95 crossings/50 min; n = 5; p > 0.05 according to Bonferroni post-test) and AMPH repeated exposure rats (Day 15: AMPH sensitization/saline: 183.60 AE 10.76 crossings/50 min; n = 5; vs. AMPH sensitization/nor-BNI: 180.00 AE 12.09 crossings/50 min; n = 5; p > 0.05 according to Bonferroni post-test).
To assess the contribution of KOR to changes in basal and stimulated DA levels that accompanied the expression of AMPH locomotor sensitization, conventional microdialysis experiments were carried out 24 h after the last injection of AMPH (Fig. 1a, day 16 ) in saline and nor-BNI exposed rats (Fig. 1a, day 12) .
Effect of systemic nor-BNI administration on basal and stimulated DA levels in the DLS
To compare the effect of local and systemic blocking KOR on DLS DA levels of control rats, conventional microdialysis experiments were carried out 3 days after the systemic administration of nor-BNI (10 mg/kg). Local blocking KOR was assessed perfusing nor-BNI (250 lM) into DLS during the conventional microdialysis. As shown in Fig. 4(a) , the systemic administration of nor-BNI is accompanied by a significant increase in basal DA dialysate (control/saline: 0.73 AE 0.14 nM; n = 5; vs. control/nor-BNI-System: 1.08 AE 0.11 nM; n = 5; p < 0.05 according to unpaired t-test).
Reproducing the results observed in Fig. 2(a) , the local perfusion of nor-BNI (250 lM) increase basal DA dialysate Fig. 3 The systemic administration of nor-binaltorphimine (nor-BNI) does not modify the amphetamine (AMPH)-induced locomotor activity. Sensitized group was pre-treated with AMPH for 5 days (1-5); singledose AMPH pre-exposed rats were pre-treated with saline (days 1-5). After 5 days of withdrawal, both groups were exposed to an acute injection of AMPH (1.0 mg/kg). The effect of blocking kappa-opioid receptors on AMPH expression was assessed 3 days after the systemic administration of nor-BNI (10 mg/kg). (single AMPH/saline n = 5 rats; single AMPH/nor-BNI n = 5; AMPH sensitized/saline n = 5 rats; AMPH sensitized/nor-BNI n = 5 rats). ** p < 0.001 Fig. 4 Effect of nor-binaltorphimine (nor-BNI) on dorsolateral striatum basal and stimulated dopamine (DA) release in amphetamine (AMPH)-exposed rats. DA release was stimulated by local perfusion of high K + -Krebs-Ringer phosphate (KRP) (40 and 70 mM) and KRP-AMPH (100 lM). In control rats, the effect of blocking kappa-opioid receptors on stimulated DA release was studied after the local perfusion (nor-BNI-Perf; 250 lM) and systemic (nor-BNI-System; 10 mg/kg) administration of nor-BNI (control/saline n = 5 rats; control/nor-BNI-Perfn = 4 rats; control/nor-BNI-System n = 5 rats). In AMPH-exposed rats, DA extracellular levels were studied after systemic administration of nor-BNI (10 mg/kg). Conventional microdialysis experiments were carried out 3 days after the systemic administration of nor-BNI (single AMPH/saline n = 5 rats; single AMPH/nor-BNI n = 5; AMPH sensitized/saline n = 5 rats; AMPH-sensitized/nor-BNI n = 5 rats (control/saline: 0.73 AE 0.14 nM; n = 5; vs. control/nor-BNI-Perf: 1.26 AE 0.19 nM; n = 4; p < 0.05 according to unpaired t-test). Figure 4 (b) shows the effect of blocking KOR on DLSstimulated DA levels. A two-way ANOVA, with treatment conditions as the between-subject variable and stimulus as the within-subject variable, indicated a significant effect of treatment (F 6,54 = 11.60; p < 0.0001) and the stimulus (F 2,54 = 14.54; p = 0.0001). The interaction is considered significant (F 12,54 = 4.56; p = 0.0001). The perfusion of 70 mM K + -KRP is accompanied by a significant increase in stimulated DA levels compared to 40 mM K + -KRP (40 mM: 82.56 AE 16.93 nM; n = 5; vs. 70 mM: 156.18 AE 25.17; n = 5; p < 0.001) and Amph 100 lM -KRP (Amph 100 lM : 115.22 AE 24.97 nM; n = 5; vs. 70 mM: 156.18 AE 25.17; n = 5; p < 0.05). A Bonferroni post-test showed that DLS perfusion and systemic administration of nor-BNI significantly attenuate the increase of 70 mM K + -induced DA release (control/saline K+70 mM : 156.18 AE 25.17 nM; n = 5; vs. control/nor-BNI-Perf K+70 mM : 46.25 AE 2.37 nM; n = 4; p < 0.001; control/saline K+70 mM : 156.18 AE 25.17 nM; n = 5; vs. control/nor-BNI-System K+70 mM : 94.77 AE 9.86 nM; n = 5; p < 0.01).
Effect of systemic nor-BNI administration on basal and stimulated DA levels in the DLS after single or repeated AMPH exposure Conventional microdialysis experiments were carried out 24 h after to assess the expression of locomotor AMPH sensitization (Fig. 1a, day 16 ). The single-dose AMPH preexposed rats showed a significant decrease in basal DA dialysate compared with AMPH-sensitized rats (Fig. 4a: single AMPH/saline: 0.29 AE 0.07 nM; n = 5; vs. AMPH sensitized/saline: 1.65 AE 0.30 nM; n = 6; p < 0.05 according to Bonferroni post-test). As observed after nor-BNI perfusion (Fig. 2a) , the systemic nor-BNI administration significantly attenuated the increase in basal DA dialysate in AMPH-sensitized rats (Fig. 4a , AMPH sensitized/saline: 1.65 AE 0.30 nM; n = 6; vs. AMPH sensitized/nor-BNI: 0.56 AE 0.10 nM; n = 5; p < 0.05 according to Bonferroni post-test).
A significant decrease in high K + and Amph-stimulated DA release is observed in single-dose AMPH pre-exposed rats. The systemic administration of nor-BNI specifically attenuated the decrease in 70 mM K + -stimulated DA release (single AMPH/saline K+70 mM : 30.51 AE 1.63 nM; n = 5; vs. single AMPH/nor-BNI K+70 mM : 74.72 AE 5.71 nM; n = 5; p < 0.05). In contrast, the systemic administration of nor-BNI significantly decrease the 70 mM K + -stimulated DA release after expression of locomotor AMPH sensitization (Fig. 4b , AMPH sensitized/saline K+70 mM : 119.21 AE 13.67 nM; n = 5; vs. AMPH sensitized/nor-BNI K+70 mM : 74.31 AE 6.05 nM; n = 5; p < 0.05 according to Bonferroni post-test).
Discussion
The present results show a decrease in DA C ext after the early exposure to AMPH, while an increase in DA C ext is observed after AMPH-induced locomotor sensitization. The local and systemic administration of nor-BNI significantly attenuates the increase in Ed observed in single-dose AMPH preexposed rats. Conversely, nor-BNI administration significantly increases Ed in DLS of AMPH-sensitized rats. These findings indicate that endogenous KOR system tunes DA dynamics controlling DA uptake in the DLS during repeated exposure to AMPH. The AMPH-induced locomotor activity was not modified after the systemic administration of nor-BNI, suggesting that KOR-induced DA neuroadaptations in the DLS do not underlie the expression of AMPH locomotor sensitization.
Neuroanatomical and functional evidence points to a possible interaction between KOR and DAT (Svingos et al. 2001; Kivell et al. 2014) controlling DA extracellular levels in the striatum. In line with these evidence, our results in control rats show that both basal DA dialysate and Ed were increased during the local perfusion of nor-BNI in the DLS, hence DA C ext remains unchanged after blocking KOR (Fig. 2) . These results are consistent with a previous finding (Chefer et al. 2005 ) that endogenous KOR activity regulates DA C ext -modifying DA release and DAT activity in the NAc. Interestingly, the adaptation in the NAc is time dependent: an early increase in DA release is followed by a subsequent increase in Ed after nor-BNI injection (Chefer et al. 2005) . In the DLS a simultaneous increase in basal DA dialysate and Ed is observed after systemic and local nor-BNI administration, suggesting a tonic inhibitory control of KOR on both DA release and DAT activity in the DLS. In contrast, the acute activation of KOR increases the DA uptake in the NAc (Thompson et al. 2000) , suggesting an up-regulation of DAT activity. Evidence regard the effect of acute KOR activation on DAT activity in dorsal striatum is still preliminary. The acute administration of KOR agonist Salvinorin A decreases DA release without affecting the Ed in the dorsal striatum (Gehrke et al. 2008) . Similarly, the DA uptake is not altered in the dorsal striatum after the repeated activation of KOR (Thompson et al. 2000) . However, our evidence suggests an important role for the endogenous KOR system in control DAT activity in DLS.
The conventional microdialysis experiments show that both DLS local perfusion and systemic administration of nor-BNI decrease the high K + and AMPH-evoked DA release, indicating that effect of nor-BNI systemic administration is as a result of the local blocking of KOR in the DLS (Fig. 4) . Moreover, the decrease in stimulated DA release is consistent with previous observations indicating that conditions that increase basal DA dialysate reduces the capacity to facilitate stimulated DA overflow (Weiss et al. 1992) . The increase in DA uptake after blocking KOR may underlie to the attenuation of stimulated DA release.
It has been consistently shown that psychostimulantsinduced behavioral sensitization is associated with an increase in DA release in the NAc (Steketee and Kalivas 2011) . In line with this evidence, we showed that the AMPHinduced locomotor sensitization is accompanied by an increase in DLS DA C ext . Surprisingly, in single-dose AMPH pre-exposed rats, a significant decrease in DA C ext , as a result of a decrease in DA release and an increased Ed is observed in the DLS. Moreover, conventional microdialysis showed a significant decrease in high K + and AMPH-evoked DA release. Although it has been showed AMPH sensitization after a single dose of AMPH accompanied by an increase in stimulated DA release (Vanderschuren et al. 1999) , in our experimental conditions no significant differences were observed comparing the two injections of AMPH. These evidence suggest that early exposure to AMPH is accompanied by an attenuated nigrostriatal activity. Accordingly, the spontaneous firing rate of DA neurons in the substantia nigra pars compacta is attenuated after acute and repeated exposure to AMPH (Heidenreich and Rebec 2000) . An alternative but not exclusive hypothesis is that the significant increase in DA uptake produces a decrease in basal DA dialysate (Fig. 2) and prevents the increase in basal and stimulated DA levels (Fig. 4) . Although an immediate internalization of DAT is observed after acute exposure to AMPH (Boudanova et al. 2008) , our results suggest modifications tending to increase DAT activity after early exposure to AMPH.
As mentioned before, the acute and repeated AMPH exposure increases striatal dynorphin levels (Tzaferis and McGinty 2001) . Accordingly, in single-dose AMPH preexposed rats the local perfusion of nor-BNI is accompanied by significant attenuation in the increased Ed together with an increase in basal DA dialysate. Then, the blocking of KOR tends to normalize DA C ext and showing that endogenous KOR system contributes to increase DA uptake in DLS after early exposure to AMPH (Fig. 2) . This normalizing effect, opposite to the observed in control rats, suggests that an up-regulated endogenous KOR tone switch control on DAT activity from a basal inhibitory modulation to an increase in DA uptake. In this sense, the acute activation of KOR increases DAT surface levels (Kivell et al. 2014) . Furthermore, the conventional microdialysis in single-dose AMPH pre-exposed rats showed that systemic nor-BNI administration significantly increases 70 mM K + -evoked DA release, probably associated with the decrease in DA uptake (Fig. 4b) .
Contrary to observed in single-dose AMPH pre-exposed rats, the expression of AMPH locomotor sensitization is accompanied by a significant increase in DA C ext , associated with both an increase in basal DA dialysate levels and a decrease in Ed. A facilitation of stimulated DA release caused by repeated activation of KOR (Fuentealba et al. 2006) , associated with AMPH sensitization (Horner et al. 2009 ), could underlie the increase in DA C ext . Interestingly, the nor-BNI perfusion increases Ed leading to a normal DA C ext . These results indicate that endogenous KOR system contributes to an increase in DA C ext in the DLS facilitating DA release and attenuating the DA uptake after the expression of AMPH locomotor sensitization (Fig. 2) . Collectively, our results suggest that the endogenous kappa system during the early exposure to AMPH tends to counteract the effects of AMPH on DA release, ultimately contributing to its facilitating effects of DA release after expression of AMPH sensitization.
The DA C ext is modulated by different mechanisms located in the dopaminergic terminals. The tonic DA release is increased after blocking DAT and D2 dopaminergic receptors in both NAc and dorsal striatum (Zhang et al. 2009 ). Moreover, it has been proposed that the regulation of DA C ext in dorsal striatum depends on mechanism involving DA efflux mediated by DAT, denominated 'lateral-release'. The DA release stimulated by AMPH is a pharmacological tool to study the 'lateral-release' (Leviel 2011) . The uptake and efflux mediated by DAT are thought to be independent process, seemingly opposite and physiologically relevant (Khoshbouei et al. 2004; Garcia-Olivares et al. 2017) . In line with these evidence, our results in control rats show the increased Ed induced by nor-BNI is accompanied by a significant decrease in AMPH-evoked DA release. Similarly, the increase in Ed observed in single-dose AMPH preexposed rats is accompanied by a significant decrease in AMPH-evoked DA release. While the Ed is attenuated by nor-BNI, the AMPH-evoked DA remained reduced after blocking KOR. Because has been proposed that uptake and efflux mediated by DAT are independent processes, these results suggest that endogenous KOR tone mainly control DAT uptake in DLS.
While the endogenous KOR system contributes significantly to control DA C ext in DLS, the blocking of KOR did not modify the AMPH-induced locomotor activity, neither after a single injection of AMPH nor after AMPH expression (Fig. 3) . Although these results indicate that the endogenous KOR system does not contribute to reinforcing properties of AMPH sensitization (Vezina et al. 2002) , the blocking of KOR has shown it attenuates the cocaine reinstatement induced by foot-shock but facilitates it after an acute injection of cocaine (Beardsley et al. 2005) . Then, the role of KOR on addiction seems to be related to stress-induced relapse ( Van't Veer and Carlezon 2013) . Interestingly, the dose of systemic nor-BNI administration used in the locomotor test showed a significant anxiolytic effect in the elevated plus maze (EPM) ( Figure S3 ). These results are in line with our recent evidence suggesting that the neuroplastic changes that accompany the expression of locomotor sensitization are dissociable from neuroplastic changes underlying anxiety-like behaviors (Gatica et al. 2017) .
Taken together, our results demonstrate that single and repeated exposure to AMPH is accompanied by opposite modifications in DA dynamics in the DLS. The blocking of KOR reverses these changes in DA neurotransmissionmodifying DA release and DA uptake in the DLS. These findings suggest that endogenous KOR tunes DA dynamics controlling DAT activity in the DLS during the progression of AMPH sensitization. All experiments were conducted in compliance with the ARRIVE guidelines.
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